Group items tagged

Prathima Hospitals is a best multi specialty hospital in Hyderabad, we provides comprehensive treatment across 30 different specialties.

Dentistry is the branch of science that deals with preventing and treating dental issues. There are a total of 9 different branches or specialties in which a dentist can train and specialize in. The specialty dentists are often instated in the top hospitals to provide treatment for their patients.

Jazzy Select Elite The Jazzy Select Elite delivers a potent blend of power, performance and style. In-line, front-wheel drive technology gives the Elite excellent stability and maneuverability for solid performance indoors and out. Jazzy Select Elite Features Jazzy includes shroud and controller guards to protect against daily wear and tear. Red or blue color-through shroud. Black high-back seat with removable, replaceable back and seat covers. Dual-layer powder coated frame for increased durability. Larger foot platform. 40 amp, PG GC 3 controller. Built with ease of service in mind. Jazzy Select Elite Specifications Weight Capacity: 300 lbs. Turning Radius: 24.75" Width: 22.75" Length: 34.75" Maximum Speed Up to 4 mph Ground Clearance: 1.5" Front Wheels: 3" solid anti-tips Drive Wheels: 9" solid Rear Wheels: 6" solid casters Drivetrain: Two-motor, in-line, front-wheel drive Braking System Regenerative and electro-mechanical Suspension Type Limited High-Back Seating: 20"W x 20"D (max. dimensions) High-Back Seat-to-Floor Range: 21.5" - 23.5" Specialty Seating: 20"W x 20"D (max. dimensions) Specialty Seat-to-Floor Range: 16.5" - 18.5" Synergy Seating 20"W x 20"D (max. dimensions) Synergy Seat-to-Floor Range 17.25" - 19.25" Standard Electronics: 40A, PG GC3 Battery Size: 12 volt, U-1 (2 required) Standard Battery Charger: 3A, off-board Per-Charge Range Up to 15 miles Battery Weight: 24.5 lbs. each Base Weight: 68.5 lbs. Standard Seat Weight: 43 lbs. (comfort, high-back) Standard Seat Size: 18" x 18"-20"

Are you planning for some online shopping in this Christmas & New Year? Buy Snacks, Bars, Gluten free Foods, Drinks, Shakes and other speciality foods. Use speciality foods to lead a healthy lifestyle in the year, 2013. Get upto 18% off on best speciality food products. Offer is valid till 31st December, 2012 http://www.health-shoppe.com/Specialty-Food/

Sun Pharmaceutical Industries, India's largest drugmaker by revenue, reported a better-than-expected 5.2 per cent rise in third-quarter profit on Tuesday, driven by higher sales of its specialty drugs. The company, known for its consumer healthcare products such as Revital vitamins and pain relief medicine Volini, said it earned a consolidated net profit of 21.66 billion rupees ($265.23 million) in three months ended Dec. 31, up from 20.59 billion rupees last year. Analysts, on average, had expected the company to report a profit of 21.26 billion rupees, according to Refinitiv IBES data. Total revenue from operations climbed nearly 14 per cent to 112.41 billion rupees. Input costs rose 8.5 per cent. Drug sales in India rose 7.1 per cent to 33.92 billion rupees, whereas sales in the United States climbed 16.6 per cent to 34.66 billion rupees, with each of the two regions accounting for 31 per cent of the company's total consolidated sales. The company, founded in 1983, makes over-the-counter medications, anti-retrovirals and active pharmaceutical ingredients for chronic and acute treatments.

Walgreens Boots Alliance, Boots UK's parent company, has appointed Tim Wentforth as its new CEO, effective on 23 October. He joined WBA at a pivotal time when the company plans to downsize the business while driving execution and creating greater value for employees, patients, customers and shareholders. Wentforth replaced Rosalind Brewer, who stepped down on 1 September, after two years at the helm. He joined from Evernorth, Cigna's health services organisation based in Connecticut, where he served as its founding CEO. Prior to Cigna, he also held top roles in companies including specialty pharmacy company Accredo and pharmacy benefit manager Express Scripts.

Specialty branch of dentistry where the specialist dentist specializes in diseases of root canal and its supporting structures. Most common treatments undertaken by Endodontic is Root Canal Treatment, Endodontic treatment is required for the patients who have inflamed or infected pulp.

Recliner wheelchairs represent the highest standard in affordable quality, style and strength. The gray hammer tone finish is fashionable and durable. Comfortable padded black cloth material is re-enforced to prevent stretching and ripping. The high back includes a neck support to provide additional comfort for patient. The dual axle design allows for easy conversion from adult to hemi seat heights. They recline to full 180 degree positions, and have "Easy Adjust" foot riggings.

Healthcare has been a subject of immense importance to the humanity since its inception. Good health is the key factor to human happiness and well-being. In today's scenario, healthcare has become even more crucial.

Dr. Michael M Omidi, MD is a Doctor primarily located in Beverly Hills, CA. He has 21 years of experience. His specialties include Surgery and Plastic Surgery. Dr. Omidi has received 4 awards.

Dr. Michael M Omidi, MD is a Doctor primarily located in Beverly Hills, CA. He has 21 years of experience. His specialties include Surgery and Plastic Surgery. Dr. Omidi has received 4 awards.

Complete Medical Wellness is a multi-specialty medical group with highly qualified, board-certified, best in class doctors in the fields of Vascular Vein Treatments, Neuro Spine Treatments, Orthopedic Treatments, Pain Management Treatments, Reconstructive and Plastic Surgery, General Medicine and Cosmetics.

Dr. Madhulika Mohanty is a well known Dermatologist, and practices in Dermatologist. View specialties, procedures, educational qualifications and overview details of Dr. Madhulika Mohanty, check OPD schedule and book appointment online on credihealth.com

Dr Kshitij Bhatnagar is ENT Specialist in Kailash Hospital Noida and specializes in ENT Specialist. View specialties, procedures, educational qualifications and overview details of Dr Kshitij Bhatnagar, check OPD schedule and book appointment online on credihealth.com

GlaxoSmithKline on Wednesday (April 13) said it had agreed to buy US group Sierra Oncology, a specialist in medicines for rare forms of cancer, for $1.9 billion. The purchase, worth the equivalent of £1.6 billion, aims to support the development of new medicines alongside Sierra's bone marrow cancer treatment Momelotinib. The deal, set to be completed this year, represents a near 40-percent premium to Sierra's closing share price on Tuesday, GSK said in a statement. Momelotinib could help address the "significant unmet medical needs" of patients with the blood cancer myelofibrosis and anaemia, said GSK chief commercial officer Luke Miels. "With this proposed acquisition, we have the opportunity to potentially bring meaningful new benefits to patients and further strengthen our portfolio of specialty medicines," he added.

HayMax, manufacturer of organic, drug-free allergen barrier balms for hay fever, dust, and pet allergies, has recently won the 2023 Global 100 awards. The HayMax balm, applied around nostril rims and eye bones, is an innovative allergen blocker against pollen, dust, and pet allergens entering the body. Independent university research confirms it traps over a third of pollen, along with dust mites and pet dander, before they enter the body, according to HayMax. The drug-free balm is Soil Association-certified organic, comprising 100 per cent natural ingredients. Safe for children, pregnant, and breastfeeding women, it holds the Vegetarian Society Approved trademark. This award has come as a complete surprise to us at HayMax," said HayMax MD, Max Wiseberg. "Being held in such high regard through this global recognition is truly delightful." "The Global 100 aims to offer readers insight into firms that excel in their chosen specialties, and the award underscores hard work and innovation of various companies," said its organisers.

In partnership with the pharmaceutical company Boehringer Ingelheim, Leeds Teaching Hospitals Trust (LTHT) has recently established an innovative cardiometabolic clinic. The clinic focuses on reducing cardiovascular risk in people with diabetes who have recently been discharged from LTHT following a heart attack. It is delivered jointly by the cardiology department at Leeds General Infirmary and the diabetes services at the Trust. This is a patient-centred approach to reducing that risk, with pharmacist-delivered clinics scheduled for six to eight weeks after the heart attack. Stephen Wheatcroft, Professor of Cardiometabolic Medicine and Consultant Cardiologist at LTHT, said: "This is an exciting and innovative development, one of the first in the country. Previously, Type 2 diabetic patients presenting with heart issues would have been treated by two separate specialty teams. This is the first time there has been a specific clinic combining the cardiac and diabetes team working together. "We aim to reduce the risk for patients, with earlier multidisciplinary hospital care, to help discharged patients achieve better diabetes control, through improved medication support and optimisation, reducing the need for further treatment and future hospital stays. Overall, it will mean a better patient experience, with improved monitoring and information about treatment options, along with a reduction in waiting times for review in a specialist clinic."

Kelso Pharma, the growing UK based specialty pharma business, has announced its first product launch with the release to the UK prescription medicines market of Acepiro (Acetylcysteine) 600mg effervescent tablets. Acepiro 600 mg effervescent tablets are indicated in adults only and are being made available to hospital and community prescribers in 20 and 30 day packs, with the 30 day pack consistent with monthly prescribing. The NHS List Price for the 30 day pack is £4.40, with the 20 day pack priced at £3.65. Acepiro is being launched by Stirling Anglian Pharmaceuticals (SAP), which was acquired by Kelso Pharma one year ago, providing a new UK platform and springboard for future sales growth for the business. The new product complements SAP's existing portfolio of three medicines: CosmoCol (macrogol 3350 plus electrolytes) powder for oral solution - an osmotic laxative indicated for the treatment of chronic constipation and faecal impaction. Stirlescent (naproxen) 250mg effervescent tablets - containing naproxen, which is a non-steroidal anti-inflammatory drug (NSAID).

We all know that clothes can make us look and feel good. But did you know that they can also be used to relieve some common health issues? That's right - by choosing the right fabrics and materials, you can help alleviate conditions like skin irritations, back pain, and even headaches. So the next time you're feeling under the weather, reach for your wardrobe first - it just might hold the key to feeling better. COMPRESSION SOCKS FOR DIABETES Compression socks for diabetes have become an invaluable tool for people with diabetes to keep their lower legs healthy. Wearing compression socks can help increase circulation in diabetic patients, which is incredibly important for the health of their feet and ankles. Additionally, if the patient suffers from swelling or poor blood circulation - compression socks can help reduce those negative side effects. As a result of wearing these specialty socks, many diabetics are kept more comfortable and experience less fatigue in their legs throughout the day. With many different sizes and varieties available - it's easy for anyone suffering from diabetes to find the perfect pair of compression socks to suit their specific needs and lifestyle. There are various diabetic stockings designed for men and women. Take the time to find the right pair for you.

In a recent announcement, Mundipharma, a leading global pharmaceutical company, has announced its acquisition of all assets and rights related to rezafungin from Cidara Therapeutics. This solidified Mundipharma's dedication to managing infectious diseases and specialty care therapeutic areas, especially invasisve candidiasis which over the 15 years has seen no new therapeutic developments underscoring for alternative options. The FDA and MHRA approved rezafungin is a groundbreaking once-weekly echinocandin antifungal drug specifically designed for the treatment of invasive candidiasis in adults. While Mundipharma will oversee global commercialization efforts, Melinta Therapeutics will retain commercialization rights for rezafungin in the United States. Moreover, the acquisition empowers the pharmaceutical company with global ownership of rezafungin, encompassing its ongoing development and distribution.